Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2562808 | Pharmacological Research | 2010 | 5 Pages |
Abstract
In this study, we examined the role of phosphatidylcholine-phospholipase C (PC-PLC) and protein kinase C (PKC) in peptidoglycan (PGN)-induced nuclear factor-κB (NF-κB) activation and cyclooxygenase-2 (COX-2) expression in RAW 264.7 macrophages. PGN-induced COX-2 expression was attenuated by a PC-PLC inhibitor (D609) and by PKC inhibitors (Go 6976 and Ro 31-8220), but not by a phosphatidylinositol-PLC (PI-PLC) inhibitor (U-73122). PGN caused an increase in PKC activity, and this effect was inhibited by D609, Go 6976, and Ro 31-8220, but not by U-73122. Furthermore, the PGN-mediated increases in κB-luciferase activity were also inhibited by D609 and Ro 31-8220. Our data demonstrate that PGN activates PC-PLC which induces PKC activation; this in turn initiates NF-κB activation, and ultimately induces COX-2 expression in RAW 264.7 macrophages.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Jam-Inn Tzeng, Bing-Chang Chen, Huey-Mei Chang, Jhi-Joung Wang, Munisamy Sureshbabu, Ming-Hsien Chien, Ming-Jen Hsu, Mauo-Ying Bien, Wen-Ta Chiu, Chuang-Ye Hong, Chien-Huang Lin,